CB Herald is a news publication agency.

banner

World & Politics

by Joseph Wilson

AliquantumRx Inc. today announced positive regulatory feedback from its Type B pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of …

banner
banner
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?